Metabolic reprogramming and alteration of the redox state in hyper-productive MDCK cells for influenza a virus production. (October 2022)

• Record Type: Journal Article
• Authors: Ye, Qian; Liu, Xuping; Wan, Yuxiang; Tan, Wen-Song; Zhao, Liang
• Is Part Of: Biologicals. Volume 80(2022)
• Page Start: 35
• Page End: 42
• Publication Date: 2022-10
• Subjects: Influenza a virus -- Productive cell line -- MDCK cells -- Metabolic reprogramming -- Reactive oxygen species; Biological products -- Standards -- Periodicals; Biological Products -- Periodicals; Biological Products -- standards -- Periodicals; Produits biologiques -- Normes -- Périodiques; Biological products -- Standards; Periodicals; 615.37
• DOI: 10.1016/j.biologicals.2022.08.004
• Languages: English
• ISSNs: 1045-1056

Abstract

Abstract: Influenza is a global public health issue leading to widespread morbidity and mortality with devastating economic loss annually. Madin-Darby Canine Kidney (MDCK) cell line has been a major cell line for influenza vaccine applications. Though many details of the host metabolic responses upon influenza A virus (IAV) infection have been documented, little is known about the metabolic reprogramming features of a hyper-productive host for IAV vaccine production. In this study, a MDCK cell clone H1 was shown to have a particular high productivity of 30 × 10 3 virions/cell. The glucose and amino acid metabolism of H1 were evaluated, indicating that the high producer had a particular metabolic reprogramming phenotype compared to its parental cell line (P): elevated glucose uptake, superior tricarboxylic acid cycle flux, moderate amino acid consumption, and better regulation of reactive oxygen species. Combined with the stronger mitochondrial function and mild antiviral and inflammatory responses characterized previously, our results indicated that the high producer had a sufficient intracellular energy supply, and balanced substrate distribution for IAV and host protein synthesis as well as the intracellular redox status. Understanding of these metabolic alterations paves the way for the rational cell line development and reasonable process optimization for high-yield influenza vaccine production.